Compumedics logo

CMP - Compumedics News Story

A$0.4 -0.0  -4.8%

Last Trade - 1:52am

Sector
Healthcare
Size
Micro Cap
Market Cap £39.3m
Enterprise Value £38.8m
Revenue £18.9m
Position in Universe 1015th / 1948

BRIEF-Compumedics Says Neuroscan Orion Lifespan Meg Receives US FDA Approval In U.S.

Mon 17th February, 2020 1:32am
Feb 17 (Reuters) - Compumedics Ltd  CMP.AX :
    * NEUROSCAN ORION LIFESPAN MEG RECEIVES US FOOD AND DRUG
ADMINISTRATION APPROVAL IN U.S.

Source text for Eikon:  ID:nASX9r03hj 
Further company coverage:  CMP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.